Nelson Vergel
Founder, ExcelMale.com
TesoRx Pharma LLC, a pharmaceutical company, has collected $10 million in Series B-1 funding to prepare for trials of its oral form of testosterone.
The Menlo Park-based company did not disclose specific investor information but did say existing and new backers participated. Founded in 2010, it has raised a total of $11.8 million and is led by CEO Ramachandran Thirucote.
TesoRx plans to use the capital to prepare for Phase 3 testing of oral testosterone drug TSX-002 and build out its commercial manufacturing facilities.
http://www.marketwatch.com/story/te...urologist-as-chief-medical-officer-2014-08-05
The Menlo Park-based company did not disclose specific investor information but did say existing and new backers participated. Founded in 2010, it has raised a total of $11.8 million and is led by CEO Ramachandran Thirucote.
TesoRx plans to use the capital to prepare for Phase 3 testing of oral testosterone drug TSX-002 and build out its commercial manufacturing facilities.
http://www.marketwatch.com/story/te...urologist-as-chief-medical-officer-2014-08-05